Senores Pharmaceuticals Limited

NSE: SENORES · Healthcare

₹1,161.00-2.26%06 Nov 2026

Ask the data

Instant answers about Senores Pharmaceuticals Limited — computed from its filings, no language model

Market cap₹5,346 cr

Current price₹1,161.00

High / Low₹1,551 / ₹710

P/E52.5

P/B5.33

Book value₹217.8

ROE10.2%

ROCE14.9%

Debt / equity0.39

Dividend yield—

EPS (TTM)₹22.12

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY25	FY26
Revenue	398.2	632.6
EBITDA	89.7	168.3
Operating margin	22.5%	26.6%
Interest	21.6	25.0
Depreciation	16.8	31.2
Profit before tax	70.6	159.1
Tax	12.2	37.6
Net profit	58.3	0.0
EPS ₹	16.12	26.39
Operating cash flow	-45.9	62.0
Capex	157.5	240.1
Dividend paid	0.0	0.0
Total assets	1,226.9	1,603.8
Equity	786.2	933.6

Quarterly performance

last 8 quarters · ₹ crore

	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	103.0	114.2	138.0	161.8	174.6	175.2	180.2	192.3
Operating profit	25.7	19.4	34.2	49.5	54.0	47.5	53.8	57.7
Operating margin	24.9%	17.0%	24.8%	30.6%	30.9%	27.1%	29.8%	30.0%
Other income	5.2	11.8	3.4	5.4	3.8	17.7	2.8	8.9
Interest	6.2	5.3	5.0	6.2	5.3	8.5	7.2	8.8
Depreciation	4.2	5.2	6.0	8.1	7.8	9.3	9.9	10.2
Profit before tax	20.5	20.7	26.5	40.6	44.6	47.4	39.5	47.6
Tax	4.0	2.7	5.3	10.5	11.0	10.7	9.0	11.0
Net profit	17.2	18.0	19.7	32.4	31.7	0.0	30.7	39.5
EPS ₹	5.04	3.81	4.60	6.54	7.29	7.96	6.61	8.85
Revenue YoY	—	—	—	—	69.4%	53.4%	30.6%	18.9%
Profit YoY	—	—	—	—	84.3%	-100.0%	55.7%	22.0%

Returns & margins

trailing-twelve-month, per quarter

	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	10.7%	12.5%	9.0%	10.1%	10.2%
ROCE	12.5%	14.8%	14.6%	15.8%	14.9%
Net margin	16.9%	17.3%	12.9%	13.7%	14.1%
EBITDA margin	24.9%	26.7%	28.5%	29.6%	29.5%
Debt / equity	0.28	0.28	0.35	0.35	0.39
Interest coverage	5.77	7.06	7.36	7.34	7.02
Asset turnover	0.40	0.46	0.40	0.43	0.43

Balance sheet

equity vs borrowings over time · ₹ crore

	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	46.0	46.0	46.0	46.0
Other equity / reserves	740.1	768.0	887.5	956.9
Total equity	786.2	814.0	933.6	1,003.0
Borrowings	304.8	231.8	327.1	394.5
Current liabilities	240.7	277.7	424.0	411.6
Non-current liabilities	173.9	176.0	215.3	237.5
Total assets	1,226.9	1,288.2	1,603.8	1,680.6
Property, plant & equipment	198.8	244.7	331.4	359.9
Capital work-in-progress	44.2	16.0	17.5	31.1
Investments	0.0	1.8	4.3	5.9
Inventories	56.6	62.6	89.3	97.6
Receivables	123.9	199.5	324.8	253.2
Cash & equivalents	105.4	86.0	45.5	18.0

Cash flow

annual · ₹ crore · line = free cash flow

	FY25	FY26
Cash from operations	-45.9	62.0
Cash from investing	-429.5	-120.6
Cash from financing	573.1	-1.3
Capex	157.5	240.1
Free cash flow	-203.4	-178.1
Dividends paid	0.0	0.0

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹359.9 cr21%

CWIP

₹31.1 cr2%

Investments

₹5.9 cr0%

Inventories

₹97.6 cr6%

Receivables

₹253.2 cr15%

Cash & equivalents

₹18.0 cr1%

Other assets

₹914.9 cr54%

Peer comparison

largest in Healthcare · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Sun Pharmaceutical Industries Ltd.	4,46,270	1,860.00	40.7	5.00	12.3%
Divi's Laboratories Ltd.	2,73,493	10,320.50	93.5	16.32	17.5%
Torrent Pharmaceuticals Ltd.	1,80,671	4,750.00	85.1	9.83	11.6%
Laurus Labs Ltd.	1,26,430	2,340.00	94.4	20.86	22.1%
Apollo Hospitals Enterprise Ltd.	1,21,453	8,446.00	54.2	11.45	21.1%
Zydus Lifesciences Ltd.	1,19,550	1,197.90	28.6	4.30	15.0%
Dr. Reddy's Laboratories Ltd.	1,14,646	1,373.00	40.9	2.95	7.2%
Cipla Ltd.	1,13,988	1,411.00	39.3	3.22	8.2%
Mankind Pharma Ltd.	1,04,902	2,540.00	46.7	5.97	12.8%
Aurobindo Pharma Ltd.	1,03,572	1,800.00	26.0	2.63	10.1%
Senores Pharmaceuticals Limited	5,346	1,161.00	52.5	5.33	10.2%

StoxGud checklist: Neutral setup · 6/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-16.5%

6 months+24.6%

1 year+50.0%

3Y CAGR—

5Y CAGR—

10Y CAGR—

50-day avg₹1,342.92

200-day avg₹1,122.66

RSI (14)36

FAQs

What is the share price of Senores Pharmaceuticals Limited?

Senores Pharmaceuticals Limited (SENORES) closed at ₹1,161.00 on NSE on 06 Nov 2026.

What is the market cap of Senores Pharmaceuticals Limited?

₹5,346 crore at the latest close.

What is the P/E ratio of Senores Pharmaceuticals Limited?

52.5, on trailing-twelve-month earnings from its filings.

How fast is Senores Pharmaceuticals Limited growing?

Senores Pharmaceuticals Limited: Latest-quarter revenue is up 18.9% year on year, profit up 22.0%.

How profitable is Senores Pharmaceuticals Limited?

On a trailing-twelve-month basis return on equity is 10.2%, return on capital employed 14.9%, operating margin 29.5%, net margin 14.1%.

How much debt does Senores Pharmaceuticals Limited have?

Senores Pharmaceuticals Limited is lightly geared: debt to equity is 0.39 with borrowings of ₹394 cr against cash of ₹18 cr (balance sheet of 2026-09-30). Operating profit covers interest 7.0 times.

Financials parsed from Senores Pharmaceuticals Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from DEC '24, annual from FY25, balance sheet from Mar '25. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.